Abstract
Anxiety involves abnormal glucocorticoid signalling and altered glia-neuron communication in brain regions processing emotional responses. Adenosine A2A receptor (A2AR) blockade ameliorates mood and memory impairments by preventing synaptic dysfunction and astrogliosis. Since the glucocorticoid dexamethasone (DEX) can mimic early life-stress conditions, leading to anxiety-like behaviours, we now tested if A2AR blockade prevents alterations in the morphology and function of astrocytes exposed to DEX. Cultured astrocytes exposed to DEX exhibited an up-regulation of astrocytic markers (GFAP, connexin-43 and glutamine synthetase), as well as of A2AR. Moreover, DEX enhanced ATP and glutamate release and increased basal astrocytic Ca2+ levels. The selective A2AR antagonist SCH58261 prevented DEX-induced alterations in ATP release and basal Ca2+ levels but did not affect DEX-induced alteration of glutamate release and astrocytic markers. These findings suggest that alterations in astrocytes function, which might contribute to abnormal glucocorticoid brain signalling, are controlled by A2AR, and therefore, reinforce the relevance of A2AR as a potential therapeutic target to manage mood disorders.
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Drozdowicz LB, Bostwick JM (2014) Psychiatric adverse effects of pediatric corticosteroid use. Mayo Clin Proc 89:817–834. https://doi.org/10.1016/j.mayocp.2014.01.010
Caetano L, Pinheiro H, Patrício P et al (2017) Adenosine A2A receptor regulation of microglia morphological remodeling-gender bias in physiology and in a model of chronic anxiety. Mol Psychiatry 22:1035–1043. https://doi.org/10.1038/mp.2016.173
Duarte JM, Gaspar R, Caetano L et al (2018) Region-specific control of microglia by adenosine A2A receptors: uncoupling anxiety and associated cognitive deficits in female rats. Glia 67:182–192. https://doi.org/10.1002/glia.23476
Bergink V, Van Megen HJGM, Westenberg HGM (2004) Glutamate and anxiety. Eur Neuropsychopharmacol 14:175–183. https://doi.org/10.1016/S0924-977X(03)00100-7
Bak LK, Schousboe A, Waagepetersen HS (2006) The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 98:641–653. https://doi.org/10.1111/j.1471-4159.2006.03913.x
Harada K, Kamiya T, Tsuboi T (2016) Gliotransmitter release from astrocytes: functional, developmental, and pathological implications in the brain. Front Neurosci 9:499. https://doi.org/10.3389/fnins.2015.00499
Sampedro-Piquero P, Moreno-Fernández RD (2019) The forgotten cells: Role of astrocytes in mood disorders during the aging. Current Neuropharmacol 17:404–405. https://doi.org/10.2174/1570159x1705190405151808
Simard M, Couldwell WT, Zhang W et al (1999) Glucocorticoids - Potent modulators of astrocytic calcium signaling. Glia 28:1–12. https://doi.org/10.1002/(SICI)1098-1136(199910)28:1%3c1::AID-GLIA1%3e3.0.CO;2-4
Zimmer ER, Torrez VR, Kalinine E et al (2015) Long-term NMDAR antagonism correlates reduced astrocytic glutamate uptake with anxiety-like phenotype. Front Cell Neurosci 9:219. https://doi.org/10.3389/fncel.2015.00219
John CS, Sypek EI, Carlezon WA et al (2015) Blockade of the GLT-1 transporter in the central nucleus of the amygdala induces both anxiety and depressive-like symptoms. Neuropsychopharmacology 40:1700–1708. https://doi.org/10.1038/npp.2015.16
Shende VH, McArthur S, Gillies GE et al (2015) Astroglial plasticity is implicated in hippocampal remodelling in adult rats exposed to antenatal dexamethasone. Neural Plast 2015:694347. https://doi.org/10.1155/2015/694347
Domenici MR, Ferrante A, Martire A et al (2019) Adenosine A2A receptor as potential therapeutic target in neuropsychiatric disorders. Pharmacol Res 147:104338. https://doi.org/10.1016/j.phrs.2019.104338
Matos M, Augusto E, Santos-Rodrigues A et al (2012) Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes. Glia 60:702–716. https://doi.org/10.1002/glia.22290
Madeira D, Dias L, Santos P et al (2021) Association between adenosine A2A receptors and connexin 43 regulates hemichannels activity and ATP release in astrocytes exposed to amyloid-β peptides. Mol Neurobiol 58:6232–6248. https://doi.org/10.1007/s12035-021-02538-z
Pinheiro H, Gaspar R, Baptista FI et al (2018) Adenosine A2A receptor blockade modulates glucocorticoid-induced morphological alterations in axons, but not in dendrites, of hippocampal neurons. Front Pharmacol 9:219. https://doi.org/10.3389/fphar.2018.00219
Batalha VL, Ferreira DG, Coelho JE et al (2016) The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. Sci Rep 6:31493. https://doi.org/10.1038/srep31493
Batalha VL, Pego JM, Fontinha BM et al (2013) Adenosine A2A receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation. Mol Psychiatry 18:320–331. https://doi.org/10.1038/mp.2012.8
Dias L, Lopes CR, Gonçalves FQ et al (2021) Crosstalk between ATP-P2X7 and adenosine A2A receptors controlling neuroinflammation in rats subject to repeated restraint stress. Front Cell Neurosci 15:639322. https://doi.org/10.3389/fncel.2021.639322
Pekny M, Pekna M (2014) Astrocyte reactivity and reactive astrogliosis: costs and benefits. Physiol Rev 94:1077–1098. https://doi.org/10.1152/physrev.00041.2013
Rodrigues RJ, Tomé AR, Cunha RA (2015) ATP as a multi-target danger signal in the brain. Front Neurosci 9:148. https://doi.org/10.3389/fnins.2015.00148
Sahlender DA, Savtchouk I, Volterra A (2014) What do we know about gliotransmitter release from astrocytes? Philos Trans R Soc Lond B Biol Sci 369:20130592. https://doi.org/10.1098/rstb.2013.0592
Kazazoglou T, Panagiotou C, Mihailidou C et al (2021) Glutamine synthetase regulation by dexamethasone, RU486, and compound A in astrocytes derived from aged mouse cerebral hemispheres is mediated via glucocorticoid receptor. Mol Cell Biochem 476:4471–4485. https://doi.org/10.1007/s11010-021-04236-9
Jia YF, Wininger K, Ho AMC et al (2020) Astrocytic glutamate transporter 1 (GLT1) deficiency reduces anxiety- and depression-like behaviors in mice. Front Behav Neurosci 14:57. https://doi.org/10.3389/fnbeh.2020.00057
Zschocke J, Bayatti N, Clement AM et al (2005) Differential promotion of glutamate transporter expression and function by glucocorticoids in astrocytes from various brain regions. J Biol Chem 280:34924–34932. https://doi.org/10.1074/jbc.M502581200
Carmo M, Gonçalves FQ, Canas PM et al (2019) Enhanced ATP release and CD73-mediated adenosine formation sustain adenosine A2A receptor over-activation in a rat model of Parkinson’s disease. Br J Pharmacol 176:3666–3680. https://doi.org/10.1111/bph.14771
Funding
Supported by La Caixa Foundation (HP17/00523), Centro 2020 (CENTRO-01–0145-FEDER-000008:BrainHealth2020 and CENTRO-01–0246-FEDER-000010), and FCT (POCI-01–0145-FEDER-03127, UIDB/04539/2020 and IF/01492/2015). PhD grants of Daniela Madeira (SFRH/BD/139334/2018) and of Liliana Dias (SFRH/BD/147159/2019).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Ethics approval
This study was approved by the ORBEA_128_2015/04122015 and certified by Direção Geral de Alimentação e Veterinária (DGAV; 0421/000/000/2016 Ref 014,420).
Conflict of interest
RAC is a scientific consultant for the Institute for Scientific Information on Coffee. All other authors declare no conflict of interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Madeira, D., Dias, L., Santos, P. et al. Adenosine A2A receptors blockade attenuates dexamethasone-induced alterations in cultured astrocytes. Purinergic Signalling 18, 199–204 (2022). https://doi.org/10.1007/s11302-022-09864-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11302-022-09864-4